Patent · US Active

Antibody variants and uses thereof

US10759867B2 · kind B2 · utility

9Cited by
2References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 6, 2012
Grant dateSep 1, 2020
Priority date
Expiry dateMar 5, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Described herein are polypeptides and related antibodies comprising a variant Fc domain. The variant Fc domain provide for stabilized Fc:Fc interactions when the polypeptide(s), antibody or antibodies are bound to its target, antigen or antigens on the surface of a cell, thus providing for improved effector functions, such as CDC-response.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.